253 related articles for article (PubMed ID: 31207939)
1. Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice.
Tsai TH; Lee CH; Cheng CI; Fang YN; Chung SY; Chen SM; Lin CJ; Wu CJ; Hang CL; Chen WY
Cells; 2019 Jun; 8(6):. PubMed ID: 31207939
[TBL] [Abstract][Full Text] [Related]
2. Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy.
Liu X; Mujahid H; Rong B; Lu QH; Zhang W; Li P; Li N; Liang ES; Wang Q; Tang DQ; Li NL; Ji XP; Chen YG; Zhao YX; Zhang MX
J Cell Mol Med; 2018 Feb; 22(2):808-822. PubMed ID: 29063670
[TBL] [Abstract][Full Text] [Related]
3. Gemigliptin Inhibits Interleukin-1β-Induced Endothelial-Mesenchymal Transition via Canonical-Bone Morphogenetic Protein Pathway.
Hong OK; Lee SS; Yoo SJ; Lee MK; Kim MK; Baek KH; Song KH; Kwon HS
Endocrinol Metab (Seoul); 2020 Jun; 35(2):384-395. PubMed ID: 32615723
[TBL] [Abstract][Full Text] [Related]
4. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
[No Abstract] [Full Text] [Related]
5. The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis.
Kushima H; Mori Y; Koshibu M; Hiromura M; Kohashi K; Terasaki M; Fukui T; Hirano T
Cardiovasc Diabetol; 2017 Oct; 16(1):122. PubMed ID: 28969637
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity.
Yan F; Zhang GH; Feng M; Zhang W; Zhang JN; Dong WQ; Zhang C; Zhang Y; Chen L; Zhang MX
Mol Med; 2015 Feb; 21(1):15-25. PubMed ID: 25715248
[TBL] [Abstract][Full Text] [Related]
7. TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling.
Cooley BC; Nevado J; Mellad J; Yang D; St Hilaire C; Negro A; Fang F; Chen G; San H; Walts AD; Schwartzbeck RL; Taylor B; Lanzer JD; Wragg A; Elagha A; Beltran LE; Berry C; Feil R; Virmani R; Ladich E; Kovacic JC; Boehm M
Sci Transl Med; 2014 Mar; 6(227):227ra34. PubMed ID: 24622514
[TBL] [Abstract][Full Text] [Related]
8. Mangiferin alleviates diabetic pulmonary fibrosis in mice via inhibiting endothelial-mesenchymal transition through AMPK/FoxO3/SIRT3 axis.
Fu TL; Li GR; Li DH; He RY; Liu BH; Xiong R; Xu CZ; Lu ZL; Song CK; Qiu HL; Wang WJ; Zou SS; Yi K; Li N; Geng Q
Acta Pharmacol Sin; 2024 May; 45(5):1002-1018. PubMed ID: 38225395
[TBL] [Abstract][Full Text] [Related]
9. Endothelial-to-mesenchymal transition shapes the atherosclerotic plaque and modulates macrophage function.
Helmke A; Casper J; Nordlohne J; David S; Haller H; Zeisberg EM; von Vietinghoff S
FASEB J; 2019 Feb; 33(2):2278-2289. PubMed ID: 30260706
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-92a -mediated endothelial to mesenchymal transition controls vein graft neointimal lesion formation.
Zhong CM; Li S; Wang XW; Chen D; Jiang ZL; Zhang C; He XJ; Huang C; Jiang YJ; Wu QC
Exp Cell Res; 2021 Jan; 398(1):112402. PubMed ID: 33253710
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 and vitamin D: anti-inflammatory response in diabetic kidney disease in db/db mice and in cultured endothelial cells.
Einbinder Y; Ohana M; Benchetrit S; Zehavi T; Nacasch N; Bernheim J; Zitman-Gal T
Diabetes Metab Res Rev; 2016 Nov; 32(8):805-815. PubMed ID: 26991522
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension.
Wang J; Yu M; Xu J; Cheng Y; Li X; Wei G; Wang H; Kong H; Xie W
J Biomed Sci; 2019 Jan; 26(1):6. PubMed ID: 30634956
[TBL] [Abstract][Full Text] [Related]
13. Liraglutide, a Glucagon-like Peptide-1 Receptor Agonist, Attenuates Development of Cardiac Allograft Vasculopathy in a Murine Heart Transplant Model.
Wang Z; Wang M; Hu X; Li Y; Ma D; Li S; Zhao G; Xie Y; Shu Y; Yang J
Transplantation; 2019 Mar; 103(3):502-511. PubMed ID: 30211824
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1-induced SMAD2/3/4 activation promotes RELM-β transcription to modulate the endothelium-mesenchymal transition in human endothelial cells.
Jiang Y; Zhou X; Hu R; Dai A
Int J Biochem Cell Biol; 2018 Dec; 105():52-60. PubMed ID: 30120989
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition.
Chen XY; Lv RJ; Zhang W; Yan YG; Li P; Dong WQ; Liu X; Liang ES; Tian HL; Lu QH; Zhang MX
Oncotarget; 2016 May; 7(21):31053-66. PubMed ID: 27105518
[TBL] [Abstract][Full Text] [Related]
16. The neuroprotection of liraglutide on diabetic cognitive deficits is associated with improved hippocampal synapses and inhibited neuronal apoptosis.
Yan W; Pang M; Yu Y; Gou X; Si P; Zhawatibai A; Zhang Y; Zhang M; Guo T; Yi X; Chen L
Life Sci; 2019 Aug; 231():116566. PubMed ID: 31201846
[TBL] [Abstract][Full Text] [Related]
17. Cathelicidin-related antimicrobial peptide protects against cardiac fibrosis in diabetic mice heart by regulating endothelial-mesenchymal transition.
Zheng X; Peng M; Li Y; Wang X; Lu W; Wang X; Shan Y; Li R; Gao L; Qiu C
Int J Biol Sci; 2019; 15(11):2393-2407. PubMed ID: 31595157
[No Abstract] [Full Text] [Related]
18. A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model.
Gaspari T; Liu H; Welungoda I; Hu Y; Widdop RE; Knudsen LB; Simpson RW; Dear AE
Diab Vasc Dis Res; 2011 Apr; 8(2):117-24. PubMed ID: 21562063
[TBL] [Abstract][Full Text] [Related]
19. Phloretin ameliorates diabetes-induced endothelial injury through AMPK-dependent anti-EndMT pathway.
Mao W; Fan Y; Wang X; Feng G; You Y; Li H; Chen Y; Yang J; Weng H; Shen X
Pharmacol Res; 2022 May; 179():106205. PubMed ID: 35381340
[TBL] [Abstract][Full Text] [Related]
20. Shear Stress Alterations Activate BMP4/pSMAD5 Signaling and Induce Endothelial Mesenchymal Transition in Varicose Veins.
Chandran Latha K; Sreekumar A; Beena V; S S BR; Lakkappa RB; Kalyani R; Nair R; Kalpana SR; Kartha CC; Surendran S
Cells; 2021 Dec; 10(12):. PubMed ID: 34944071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
